Biol stock forecast.

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 3.29B. -13.94%. Get the latest Roche Holding AG (RO) real-time quote, historical ...Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all ... The Tivic Health Systems, Inc. stock price gained 4.78% on the last trading day (Friday, 24th Nov 2023), rising from $2.09 to $2.19. During the last trading day the stock fluctuated 11.35% from a day low at $2.07 to a day high of $2.30. The price has risen in 6 of the last 10 days and is up by 85.59% over the past 2 weeks.Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic ...According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. Learn more on BIOL's analyst rating history.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.BIOLASE (BIOL) stock consensus forecasts for the month and 2023 - 2027. Last update: 06/15/2023, 10:01 PM. Brief information about BIOLASE, Inc. ...

BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.The 1 Wall Street analysts offering Surface Oncology stock forecast in the last 6 months have average price target of $5.0 with a high forecast of $5.0 and a low forecast of $5.0. The average Surface Oncology stock forecast represents a 367.29% increase from the last price of $1.07000005245209. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Cathie Wood. Brendan McDermid/Reuters. Ark Invest CEO Cathie Wood expects synthetic-biology companies to take off in the next five years. "There is going to be explosive growth that most people in ...Oct 25, 2023 · Ticker: BIOL. Sector: Healthcare. Closing price of the last trading day: $1.66. Last trading day: 10/25/2023. Analyst forecast price: $20.5. 52-week high/low: $23.48 / $3.3. Shares of BIOLASE, Inc. are traded on the stock exchange under the ticker BIOL, marking their space in the competitive " Healthcare " sector.

What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Q4 revenues are expected to be in a range of $12.2 million to $12.5 million, well above consensus expectations of $10.7 million and up approximately 30% sequentially and 45% year-over-year ...

Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. NVIDIA Corporation Common Stock. $439.77 -0.64 -0.15%. VFS. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours ...Entera Bio Ltd.’s stock was trading at $ 0.70 on Nov 13, 2023 a day before the last earnings report was released. Following the release of the earnings report, ENTX’s price increased to $ 0.73 on Nov 15, 2023, recording a …Stock analysis for Biolase Inc (BIOL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BIOL: BIOLASE Inc - Stock Price, Quote and News - CNBCBIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1

Find the latest Rivian Automotive, Inc. (RIVN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a …Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...The 1 Wall Street analysts offering BIOLASE stock forecast in the last 6. Forecast target price for 11-06-2022. ... According to our current BIOL stock forecast the value of BIOLASE Inc. BIOL was valued at 161. Shares will drop by. The 4 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of. BIOLASE stock …

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -7.46M. 45.53%. Get the latest Generation Bio Co (GBIO) real-time quote, historical ...BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire - Wed Sep 13, 10:16PM CDT. /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten...

Analyst projections state that BIOL is forecast to be at a low of $4.00 and a high of $40.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2295.21% from its current level, while the stock would need to crash -139.52% from its current level to reach the projected low. Biolase Inc (BIOL) estimates and ...Find the latest 2seventy bio, Inc. (TSVT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year.BIOLASE (BIOL) stock consensus forecasts for the month and 2023 - 2027. Last update: 06/15/2023, 10:01 PM. Brief information about BIOLASE, Inc. ...According to Biolase 's latest financial reports and stock price the company's current number of shares outstanding is 1,179,000. At the end of 2023 the ...When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...BIOLASE Stock Forecast 23 Nov. Presumably, on 11/23/2023, the price of shares will be in the range of $1.42 - $1.48. A $0.07 range width can provide 4.64% volatility. The weighted average price of this range is at $1.44, which is $0.00 lower than the previous day's weighted average price.BIOLASE (BIOL) stock consensus forecasts for the month and 2023 - 2027. Last update: 06/15/2023, 10:01 PM. Brief information about BIOLASE, Inc. ...

PLoS Comput Biol 10(11): e1003892. doi:10.1371 ... Finally, economic applications include attempts to forecast movie ticket sales [24] and stock prices [25].

Find the latest ImmunityBio, Inc. (IBRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.1500 +0.0600 (+5.50%) At close: 03:59PM EST 1.1300... BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.In that case, then, we find that the current price level is -1664.71% off the targeted high while a plunge would see the stock gain -1664.71% from current levels. Intelligent Bio Solutions Inc (INBS) estimates and forecasts. Figures show that Intelligent Bio Solutions Inc shares have outperformed across the wider relevant industry.7 Best-Performing Biotech ETFs for November 2023. Biotech and health care exchange-traded funds let you invest in dozens or even hundreds of companies working on groundbreaking treatments ...BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $21.50, which would result in a potential upside of approximately 1753.45% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $2.50.Sep 20, 2020 · Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak ( OTRK 3.67%) , Nano-X Imaging ( NNOX 14.20% ... Unlock tomorrow's (BIOL) stock trends with our detailed analysis. Get insights on BIOLASE, Inc.'s performance, backed by data-driven predictions for informed investment.Sep 12, 2020 · Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart. Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last March. Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.

Amgen ( AMGN, $252.17), founded in 1980, is a pioneer in biologics. Total product sales accounted for 93.5% of AMGN's 2021 revenues. The company's three top-selling drugs are Enbrel for ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.BIOL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. EST...The CABA stock price is -20.72% off its 52-week high price of $19.34 and 72.35% above the 52-week low of $4.43. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.71 million shares traded. The 3-month trading volume is 1.11 million shares. ... Cabaletta Bio Inc (CABA) estimates and forecasts.Instagram:https://instagram. nysearca spygbest lithium etfbuy bluesky stockthomas peter roth Find real-time EVLO - Evelo Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you. good gold companies to invest indakota gold stock Wall Street Stock Market & Finance report, prediction for the future: You'll find the Sorrento Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Sorrento Therapeutics's SRNE shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ... how much is a 1979 silver dollar worth BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · Their BIOL share price forecasts range from $5.00 to $14.00. On average, they anticipate the company's share price to reach $9.50 in the next year. This suggests a possible upside of 2,251.5% fromThe Ideanomics stock price gained 1.38% on the last trading day (Monday, 20th Nov 2023), rising from $2.18 to $2.21. During the last trading day the stock fluctuated 5.81% from a day low at $2.15 to a day high of $2.28. The price has risen in 6 of the last 10 days but is still down by -5.15% for this period. Volume has increased on the last day ...